164 related articles for article (PubMed ID: 30986735)
1. Comparison of 71 bipolar disorder pharmacotherapies for kidney disorder risk: The potential hazards of polypharmacy.
Nestsiarovich A; Kerner B; Mazurie AJ; Cannon DC; Hurwitz NG; Zhu Y; Nelson SJ; Oprea TI; Unruh ML; Crisanti AS; Tohen M; Perkins DJ; Lambert CG
J Affect Disord; 2019 Jun; 252():201-211. PubMed ID: 30986735
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder.
Nestsiarovich A; Kerner B; Mazurie AJ; Cannon DC; Hurwitz NG; Zhu Y; Nelson SJ; Oprea TI; Crisanti AS; Tohen M; Perkins DJ; Lambert CG
Psychoneuroendocrinology; 2020 Feb; 112():104511. PubMed ID: 31744781
[TBL] [Abstract][Full Text] [Related]
3. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.
Goldberg JF; Brooks JO; Kurita K; Hoblyn JC; Ghaemi SN; Perlis RH; Miklowitz DJ; Ketter TA; Sachs GS; Thase ME
J Clin Psychiatry; 2009 Feb; 70(2):155-62. PubMed ID: 19210946
[TBL] [Abstract][Full Text] [Related]
4. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
5. Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study.
Wu CS; Wu KY; Lo YR; Huang YW; Tsai YT; Li Y; Tsai HJ
J Affect Disord; 2018 Jan; 226():77-84. PubMed ID: 28964996
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive comparison of monotherapies for psychiatric hospitalization risk in bipolar disorders.
Nestsiarovich A; Mazurie AJ; Hurwitz NG; Kerner B; Nelson SJ; Crisanti AS; Tohen M; Krall RL; Perkins DJ; Lambert CG
Bipolar Disord; 2018 Dec; 20(8):761-771. PubMed ID: 29920885
[TBL] [Abstract][Full Text] [Related]
7. Use of Lithium and Anticonvulsants and the Rate of Chronic Kidney Disease: A Nationwide Population-Based Study.
Kessing LV; Gerds TA; Feldt-Rasmussen B; Andersen PK; Licht RW
JAMA Psychiatry; 2015 Dec; 72(12):1182-91. PubMed ID: 26535805
[TBL] [Abstract][Full Text] [Related]
8. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
9. Psychotropic polypharmacy for the treatment of bipolar disorder in Taiwan.
Hung GC; Yang SY; Chen Y; Lin SK
Psychiatr Serv; 2014 Jan; 65(1):125-8. PubMed ID: 24382766
[TBL] [Abstract][Full Text] [Related]
10. Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort.
Lambert CG; Mazurie AJ; Lauve NR; Hurwitz NG; Young SS; Obenchain RL; Hengartner NW; Perkins DJ; Tohen M; Kerner B
Bipolar Disord; 2016 May; 18(3):247-60. PubMed ID: 27226264
[TBL] [Abstract][Full Text] [Related]
11. Bipolar disorder and the risk of fracture: A nationwide population-based cohort study.
Su JA; Cheng BH; Huang YC; Lee CP; Yang YH; Lu ML; Hsu CY; Lee Y; McIntyre RS; Chin Lin T; Chin-Hung Chen V
J Affect Disord; 2017 Aug; 218():246-252. PubMed ID: 28477503
[TBL] [Abstract][Full Text] [Related]
12. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
13. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
Ventriglio A; Vincenti A; Centorrino F; Talamo A; Fitzmaurice G; Baldessarini RJ
Int Clin Psychopharmacol; 2011 Mar; 26(2):88-95. PubMed ID: 21030870
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004.
Wolfsperger M; Greil W; Rössler W; Grohmann R
J Affect Disord; 2007 Apr; 99(1-3):9-17. PubMed ID: 16989907
[TBL] [Abstract][Full Text] [Related]
15. The contemporary face of bipolar illness: complex diagnostic and therapeutic challenges.
Fountoulakis KN
CNS Spectr; 2008 Sep; 13(9):763-74, 777-9. PubMed ID: 18849896
[TBL] [Abstract][Full Text] [Related]
16. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
17. Using Machine Learning Imputed Outcomes to Assess Drug-Dependent Risk of Self-Harm in Patients with Bipolar Disorder: A Comparative Effectiveness Study.
Nestsiarovich A; Kumar P; Lauve NR; Hurwitz NG; Mazurie AJ; Cannon DC; Zhu Y; Nelson SJ; Crisanti AS; Kerner B; Tohen M; Perkins DJ; Lambert CG
JMIR Ment Health; 2021 Apr; 8(4):e24522. PubMed ID: 33688834
[TBL] [Abstract][Full Text] [Related]
18. Degree of exposure to psychotropic medications and mortality in people with bipolar disorder.
Lin CC; Yeh LL; Pan YJ
Acta Psychiatr Scand; 2023 Feb; 147(2):186-197. PubMed ID: 36217288
[TBL] [Abstract][Full Text] [Related]
19. Polypharmacy and suicide attempts in bipolar disorder.
Gazalle FK; Hallal PC; Tramontina J; Rosa AR; Andreazza AC; Zanatto V; Santin A; Kapczinski F; Ceresér KM
Braz J Psychiatry; 2007 Mar; 29(1):35-8. PubMed ID: 17435926
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
